Chad Therapeutics (CHADQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-1988 | 03-1987 | 03-1986 | 03-1985 | 03-1984 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 141 | 98 | 56 | 109 | 198 |
| Marketable Securities | 0 | 0 | 624 | 1,391 | 2,705 |
| Receivables | 172 | 124 | 38 | 24 | 16 |
| Inventories | 47 | 82 | 78 | 170 | 96 |
| Other current assets | 14 | 23 | 15 | 8 | 17 |
| TOTAL | $374 | $327 | $811 | $1,702 | $3,033 |
| Non-Current Assets | |||||
| PPE Net | 25 | 56 | 156 | 185 | 185 |
| Other Non-Current Assets | 2 | 6 | 5 | 9 | 10 |
| TOTAL | $27 | $62 | $161 | $194 | $195 |
| Total Assets | $401 | $389 | $972 | $1,895 | $3,227 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 0 | 0 | 3 | 6 |
| Accounts payable and accrued liabilities | 21 | 8 | 27 | 19 | 50 |
| Accrued Expenses | 79 | 45 | 30 | 8 | 4 |
| TOTAL | $101 | $53 | $57 | $30 | $63 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | 0 | 0 | 2 | 10 |
| TOTAL | $0 | $0 | $0 | $2 | $10 |
| Total Liabilities | $101 | $53 | $57 | $32 | $72 |
| Shareholders' Equity | |||||
| Common Shares | 4,327 | 4,327 | 4,327 | 4,327 | 4,327 |
| Retained earnings | -4,196 | -3,992 | -3,412 | -2,464 | -1,172 |
| Other shareholders' equity | 168 | 0 | 0 | 0 | 0 |
| TOTAL | $300 | $336 | $915 | $1,864 | $3,155 |
| Total Liabilities And Equity | $401 | $389 | $972 | $1,895 | $3,227 |